Browse the evidence

Weight loss in obese, hyperandrogenic, amenorrheic women significantly reduces plasma testosterone and LH levels, leading to improved menstrual cyclicity and hirsutism.

For obese women with irregular periods and high male hormones, losing weight through a standard calorie-restricted diet (1000-1500 calories daily) for 6-12 months is a highly effective medical intervention. It lowers testosterone and LH, which often restores ovulation and reduces excess hair growth, regardless of whether they have polycystic ovaries or not.

Weight loss reduces glucose-stimulated insulin levels, and this reduction correlates with the decrease in testosterone, suggesting insulin resistance drives hyperandrogenism.

High insulin levels contribute to high male hormones in obese women. Losing weight lowers insulin, which in turn helps lower testosterone. Managing insulin through diet is key to treating hormonal imbalances.

Obesity impairs the immune response to pathogens, increasing susceptibility to severe infections like influenza, due to defects in T cell development, function, and vaccine efficacy.

Obesity weakens your body's ability to fight off viruses like the flu and reduces the effectiveness of vaccines. Maintaining a healthy weight is crucial for robust immune defense, especially during flu season or pandemics.

Oral administration of probiotic bacteria (specifically Lactobacillus and Bifidobacterium strains) significantly reduces serum cholesterol levels in humans and animals.

To lower cholesterol using probiotics, you must choose specific strains known for Bile Salt Hydrolase (BSH) activity, such as Lactobacillus plantarum, L. acidophilus, or Bifidobacterium species. Generic probiotics may not work. Consistent daily consumption of these specific strains (often found in fermented foods or supplements) has been shown to reduce cholesterol by 22-33% in studies, primarily by helping your body excrete bile acids, forcing your liver to use up stored cholesterol to make more.

GLP-1 receptor agonists reduce major adverse cardiovascular events (MACE) by 14% and all-cause mortality by 12% in patients with type 2 diabetes.

If you have Type 2 Diabetes and are at high risk for heart disease, ask your doctor about GLP-1 receptor agonists (like liraglutide or semaglutide). These medications have been shown to significantly reduce the risk of heart attacks, strokes, and death, in addition to helping with blood sugar control and weight loss.

Metformin reduces all-cause mortality by 36% and heart attack incidence by 39% in overweight patients with newly diagnosed type 2 diabetes without established cardiovascular disease.

If you have recently been diagnosed with Type 2 Diabetes and are overweight, metformin is likely your first medication. It not only helps control blood sugar but has been shown to significantly reduce the risk of heart attacks and death.

Endurance training reduces blood pressure primarily by lowering systemic vascular resistance through decreased sympathetic nervous system activity and renin-angiotensin system activity.

Understanding that exercise works by calming the nervous system and blood vessels can help motivate adherence, as these benefits accumulate over time with consistent training.

Satiety from protein is driven by elevated plasma amino acids, ketone body production (in low-carb contexts), and diet-induced thermogenesis, with specific proteins like whey and alpha-lactalbumin showing higher satiating efficacy due to their amino acid profiles.

Eat protein-rich meals to feel full longer. Proteins like whey and alpha-lactalbumin are particularly effective at suppressing hunger due to their amino acid content. This helps you eat less without feeling deprived.

Serum somatomedin-C (IGF-1) levels are highly sensitive to acute changes in nutritional status and correlate strongly with nitrogen balance, serving as a more responsive indicator of protein metabolism than total body nitrogen stores.

If you are monitoring your recovery from dieting or illness, serum IGF-1 (somatomedin-C) is a highly sensitive marker that reacts quickly to changes in your protein and energy intake. It changes much faster than your actual muscle mass or total body protein stores, making it a useful early warning system for nutritional deficits.

Non-alcoholic fatty liver disease (NAFLD) is associated with a 2- to 3-fold increased risk of developing type 2 diabetes (T2D), driven by hepatic insulin resistance, impaired beta-cell function, and lipotoxicity.

If you have been diagnosed with NAFLD, recognize it as a significant warning sign for type 2 diabetes. The presence of liver fat indicates underlying insulin resistance and beta-cell stress. Prioritize interventions that improve insulin sensitivity, such as weight loss and exercise, to mitigate this elevated risk.

Short-term aerobic exercise (as little as 4 days) significantly improves postprandial lipid profiles, reducing non-fasting triglycerides and LDL remnants.

You don't need to wait months to see benefits. Just 4 days of moderate exercise can help your body clear fats from your blood after meals, reducing heart disease risk. You can do this in one session or spread out over the day.

Robust skeletal muscle hypertrophy in humans requires satellite cell-mediated myonuclear addition, as expansion of the myonuclear domain beyond a threshold (~2,000 µm²) triggers the demand for new nuclei to support continued growth.

If you are struggling to add muscle size despite consistent training, your body may not be activating enough satellite cells to add new nuclei to your muscle fibers. This is often a genetic or 'non-responder' trait. To overcome this, you may need to focus on maximizing mechanical tension and recovery to stimulate the satellite cell pool, as simply training harder might not bypass this biological ceiling without the cellular machinery to support it.

Elevated plasma concentrations of branched-chain amino acids (BCAAs), specifically leucine and valine, are strongly correlated with worsening glucose homeostasis (HbA1c) and insulin resistance in obese individuals, reflecting impaired amino acid catabolism and TCA cycle inefficiency.

If you are obese and have insulin resistance, high blood levels of BCAAs (leucine, valine) are a marker of metabolic stress, not just dietary intake. Focus on improving insulin sensitivity through lifestyle changes rather than simply restricting protein, as your body may be struggling to metabolize these amino acids efficiently.

Reallocating 30 minutes per day of sedentary time to sleep duration yields beneficial associations with insulin, HOMA-S, and HOMA-β, suggesting that extending sleep can improve metabolic health markers similarly to physical activity, though with a smaller magnitude of effect on some lipids.

If you spend a lot of time sitting, try shifting 30 minutes of that sitting time into extra sleep. This can help lower insulin and improve how your body handles glucose, offering a metabolic benefit similar to, though smaller than, exercise.

The decrease in insulin resistance is independently associated with the decrease in IL-6 concentrations, while the decrease in BMI is independently associated with the decrease in CRP concentrations.

While weight loss reduces overall inflammation, the specific inflammatory marker that improves most closely tracks with insulin sensitivity (IL-6) versus body mass index (CRP). This suggests that managing insulin resistance may require specific attention to IL-6 pathways, while general weight reduction impacts CRP levels.

Caffeine and methylxanthines stimulate adipocyte lipolysis by antagonizing A1-adenosine receptors and inhibiting phosphodiesterase, thereby increasing intracellular cAMP levels.

Consuming caffeine or methylxanthines can boost fat breakdown by blocking adenosine signals and preventing cAMP breakdown. This increases free fatty acids in the blood. While it contributes to fat oxidation, it is not a magic bullet and works best alongside energy deficits.

Inulin-propionate ester (IPE) supplementation reduces systemic proinflammatory interleukin-8 (IL-8) levels in adults with overweight and obesity, an effect not observed with inulin alone.

For those managing obesity, IPE supplementation may offer an anti-inflammatory benefit by lowering IL-8, a marker linked to insulin resistance. This effect was specific to IPE and not seen with standard inulin, suggesting the targeted delivery of propionate plays a unique role in reducing systemic inflammation.

In type 2 diabetes, the presence of fatty liver is strongly correlated with visceral adipose tissue (VAT) and is associated with significantly higher insulin resistance, elevated plasma free fatty acids, and more severe dyslipidemia compared to diabetic patients without fatty liver.

If you have type 2 diabetes, getting a fatty liver is common and strongly linked to visceral fat and insulin resistance. It is not just about overall weight but specifically where fat is stored (visceral) and in the liver/muscle. This condition worsens insulin resistance and lipid profiles, so managing visceral adiposity is key to mitigating these risks.

Obesity is associated with impaired immune function, including higher incidence and severity of infectious illnesses and poor antibody responses to vaccines.

If you are obese, your immune system may not function as efficiently as that of a lean person, particularly in responding to vaccines and fighting infections. This is largely driven by hormonal factors like leptin. Maintaining a healthy weight and managing metabolic health are important for supporting robust immune defense.

Disruption of circadian rhythms (e.g., via shift work or jet lag) impairs health by desynchronizing peripheral tissue clocks from the central SCN pacemaker, leading to metabolic and endocrine dysfunction.

Your body has an internal master clock (SCN) and local clocks in organs like the liver. These must be synchronized. Shift work, late-night eating, or irregular sleep desynchronizes them, increasing disease risk. Align your sleep, light exposure, and meal times with your local day/night cycle to maintain metabolic health.

In men, chronic insomnia combined with objectively measured short sleep duration (<6 hours) is associated with a significantly increased risk of all-cause mortality, independent of common comorbidities like hypertension and diabetes.

If you are a man with chronic insomnia and you objectively sleep less than 6 hours per night, your risk of death is significantly higher than men who sleep normally, even after accounting for high blood pressure, diabetes, and other factors. This risk is driven by physiological stress (HPA axis activation). You should seek objective sleep assessment (like a sleep study) rather than relying on how you feel, and prioritize treating the insomnia as a serious medical condition.

Chronic sympathetic nervous system overactivity is a primary driver of metabolic syndrome components, including central obesity and insulin resistance, rather than merely a consequence.

If you have metabolic syndrome or central obesity, your body may be physiologically driving weight gain and insulin resistance through an overactive sympathetic nervous system. This is not just a willpower issue. Interventions that reduce sympathetic tone, such as weight loss, exercise, or specific medications (like imidazoline agonists) and devices (like renal denervation), may be necessary to break this cycle.

Daily oral administration of 100 mg DHEA for six months significantly decreases fat body mass and increases muscle strength in age-advanced men, but not in women.

If you are a man between 50 and 65, taking 100mg of DHEA daily for six months may help reduce belly fat and increase leg and back strength. However, if you are a woman, this specific protocol did not result in fat loss or muscle gain in this study, likely due to different hormonal interactions or concurrent hormone replacement therapy.

Daily oral administration of 100 mg DHEA for six months significantly increases serum IGF-I levels in both age-advanced men and women.

Taking 100mg of DHEA daily for six months will reliably raise your IGF-I levels, a marker associated with youth and anabolism, regardless of whether you are a man or woman. However, this hormonal shift alone does not guarantee muscle growth or fat loss in women.